Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Grand Pharmaceutical Group Limited ( (HK:0512) ) just unveiled an update.
Grand Pharmaceutical Group Limited has announced that its board of directors will hold a meeting on August 19, 2025, to review and approve the interim results for the first half of the year ending June 30, 2025. This meeting is significant as it will provide insights into the company’s financial performance and strategic direction, potentially impacting its market position and stakeholder interests.
More about Grand Pharmaceutical Group Limited
Grand Pharmaceutical Group Limited operates in the pharmaceutical industry, focusing on the development and distribution of medical products and services. The company is incorporated in Bermuda and is listed on the Hong Kong Stock Exchange.
Average Trading Volume: 35,017,187
Technical Sentiment Signal: Buy
Current Market Cap: HK$29.82B
Learn more about 0512 stock on TipRanks’ Stock Analysis page.